|
1
|
Vaughan S, Coward JI, Bast RC Jr, Berchuck
A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R,
Etemadmoghadam D, et al: Rethinking ovarian cancer: Recommendations
for improving outcomes. Nat Rev Cancer. 11:719–725. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gao L, Ye X, Ma RQ, Cheng HY, Han HJ, Cui
H, Wei LH and Chang XH: Low programmed cell death 5 expression is a
prognostic factor in ovarian cancer. Chin Med J (Engl).
128:1084–1090. 2015. View Article : Google Scholar
|
|
3
|
Kim MK, James J and Annunziata CM:
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce
apoptosis in ovarian cancer cells. BMC Cancer. 15:1962015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhaumik SR, Smith E and Shilatifard A:
Covalent modifications of histones during development and disease
pathogenesis. Nat Struct Mol Biol. 14:1008–1016. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kouzarides T: Chromatin modifications and
their function. Cell. 128:693–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berger SL: The complex language of
chromatin regulation during transcription. Nature. 447:407–412.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martin C and Zhang Y: The diverse
functions of histone lysine methylation. Nat Rev Mol Cell Biol.
6:838–849. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee
JW, Verdine GL, Allis CD and Roeder RG: Regulation of MLL1 H3K4
methyltransferase activity by its core components. Nat Struct Mol
Biol. 13:713–719. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shilatifard A: Molecular implementation
and physiological roles for histone H3 lysine 4 (H3K4) methylation.
Curr Opin Cell Biol. 20:341–348. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shilatifard A: The COMPASS family of
histone H3K4 methylases: Mechanisms of regulation in development
and disease pathogenesis. Annu Rev Biochem. 81:65–95. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang H, Shukla A, Wang X, Chen WY,
Bernstein BE and Roeder RG: Role for Dpy-30 in ES cell-fate
specification by regulation of H3K4 methylation within bivalent
domains. Cell. 144:513–525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Z, Augustin J, Chang C, Hu J, Shah K,
Chang CW, Townes T and Jiang H: The DPY30 subunit in SET1/MLL
complexes regulates the proliferation and differentiation of
hematopoietic progenitor cells. Blood. 124:2025–2033. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Simboeck E, Gutierrez A, Cozzuto L,
Beringer M, Caizzi L, Keyes WM and Di Croce L: DPY30 regulates
pathways in cellular senescence through ID protein expression. EMBO
J. 32:2217–2230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Varier RA and Timmers HT: Histone lysine
methylation and demethylation pathways in cancer. Biochim Biophys
Acta. 1815.75–89. 2011.
|
|
15
|
Chervona Y and Costa M: Histone
modifications and cancer: Biomarkers of prognosis. Am J Cancer Res.
2:589–597. 2012.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Liu Y, Wang Y, Chen C, Zhang J, Qian W,
Dong Y, Liu Z, Zhang X, Wang X and Zhang Z: LSD1 binds to HPV16 E7
and promotes the epithelial-mesenchymal transition in cervical
cancer by demethylating histones at the Vimentin promoter.
Oncotarget. 8:11329–11342. 2017.
|
|
18
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Steward MM, Lee JS, O’Donovan A, Wyatt M,
Bernstein BE and Shilatifard A: Molecular regulation of H3K4
trimethylation by ASH2L, a shared subunit of MLL complexes. Nat
Struct Mol Biol. 13:852–854. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee YJ, Han ME, Baek SJ, Kim SY and Oh SO:
Roles of DPY30 in the proliferation and motility of gastric cancer
cells. PLoS One. 10:e013–1863. 2015.
|
|
23
|
Knösel T, Schlüns K, Stein U, Schwabe H,
Schlag PM, Dietel M and Petersen I: Chromosomal alterations during
lymphatic and liver metastasis formation of colorectal cancer.
Neoplasia. 6:23–28. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi Y and Whetstine JR: Dynamic regulation
of histone lysine methylation by demethylases. Mol Cell. 25:1–14.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
South PF, Fingerman IM, Mersman DP, Du HN
and Briggs SD: A conserved interaction between the SDI domain of
Bre2 and the Dpy-30 domain of Sdc1 is required for histone
methylation and gene expression. J Biol Chem. 285:595–607. 2010.
View Article : Google Scholar :
|
|
26
|
Takahashi YH, Westfield GH, Oleskie AN,
Trievel RC, Shilatifard A and Skiniotis G: Structural analysis of
the core COMPASS family of histone H3K4 methylases from yeast to
human. Proc Natl Acad Sci USA. 108:20526–20531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ohtani N, Zebedee Z, Huot TJ, Stinson JA,
Sugimoto M, Ohashi Y, Sharrocks AD, Peters G and Hara E: Opposing
effects of Ets and Id proteins on p16INK4a expression during
cellular senescence. Nature. 409:1067–1070. 2001. View Article : Google Scholar : PubMed/NCBI
|
